nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An aberrant inflammatory response in severe COVID-19
|
Merad, Miriam |
|
|
29 |
7 |
p. 1043-1047 |
artikel |
2 |
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
|
Röltgen, Katharina |
|
|
29 |
7 |
p. 1063-1075 |
artikel |
3 |
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
|
Tauzin, Alexandra |
|
|
29 |
7 |
p. 1137-1150.e6 |
artikel |
4 |
Beyond neutralization for BNT162b2 mRNA vaccination
|
Damani-Yokota, Payal |
|
|
29 |
7 |
p. 1033-1035 |
artikel |
5 |
Children and SARS-CoV-2
|
Bogunovic, Dusan |
|
|
29 |
7 |
p. 1040-1042 |
artikel |
6 |
Cytosolic replication in epithelial cells fuels intestinal expansion and chronic fecal shedding of Salmonella Typhimurium
|
Chong, Audrey |
|
|
29 |
7 |
p. 1177-1185.e6 |
artikel |
7 |
Dispersal strategies shape persistence and evolution of human gut bacteria
|
Hildebrand, Falk |
|
|
29 |
7 |
p. 1167-1176.e9 |
artikel |
8 |
Global COVID-19 vaccine inequity: The scope, the impact, and the challenges
|
Asundi, Archana |
|
|
29 |
7 |
p. 1036-1039 |
artikel |
9 |
Gut microbes impact stroke severity via the trimethylamine N-oxide pathway
|
Zhu, Weifei |
|
|
29 |
7 |
p. 1199-1208.e5 |
artikel |
10 |
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
|
Fischer, Will |
|
|
29 |
7 |
p. 1093-1110 |
artikel |
11 |
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
|
Lowery, Shea A. |
|
|
29 |
7 |
p. 1052-1062 |
artikel |
12 |
Long live the king: Toxoplasma gondii nucleomodulin inhibits necroptotic cell death
|
Shallberg, Lindsey A. |
|
|
29 |
7 |
p. 1165-1166 |
artikel |
13 |
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
|
Grifoni, Alba |
|
|
29 |
7 |
p. 1076-1092 |
artikel |
14 |
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
|
Motozono, Chihiro |
|
|
29 |
7 |
p. 1124-1136.e11 |
artikel |
15 |
SnapShot: SARS-CoV-2 antibodies
|
Montefiori, David C. |
|
|
29 |
7 |
p. 1162-1162.e1 |
artikel |
16 |
The comings and goings of the healthy human gut microbiota
|
Brito, Ilana L. |
|
|
29 |
7 |
p. 1163-1164 |
artikel |
17 |
The devil in the details: Herd immunity and pandemic response
|
Schaeffer, Beau |
|
|
29 |
7 |
p. 1048-1051 |
artikel |
18 |
The success of SARS-CoV-2 vaccines and challenges ahead
|
Subbarao, Kanta |
|
|
29 |
7 |
p. 1111-1123 |
artikel |
19 |
Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis
|
Rosenberg, Alex |
|
|
29 |
7 |
p. 1186-1198.e8 |
artikel |
20 |
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
|
Case, James Brett |
|
|
29 |
7 |
p. 1151-1161.e5 |
artikel |
21 |
Virus hunters: Discovering the evolutionary origins of SARS-CoV-2
|
Banerjee, Arinjay |
|
|
29 |
7 |
p. 1031-1033 |
artikel |